AC
GILD icon

AlphaCore Capital’s Gilead Sciences GILD Stock Holding History

AlphaCore Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.11M Buy
16,707
+3,060
+22% +$403K 0.04% 301
2026
Q1 		$1.9M Sell
13,647
-3,680
-21% -$515K 0.05% 261
2025
Q4 		$2.13M Buy
17,327
+5,199
+43% +$632K 0.05% 259
2025
Q3 		$1.35M Buy
12,128
+1,982
+20% +$225K 0.05% 246
2025
Q2 		$1.12M Buy
10,146
+461
+5% +$49.1K 0.04% 238
2025
Q1 		$1.09M Buy
9,685
+154
+2% +$15.9K 0.09% 167
2024
Q4 		$880K Buy
9,531
+75
+0.8% +$6.75K 0.19% 87
2024
Q3 		$793K Sell
9,456
-619
-6% -$47.2K 0.18% 84
2024
Q2 		$691K Buy
10,075
+224
+2% +$14.9K 0.17% 86
2024
Q1 		$722K Sell
9,851
-368
-4% -$28.3K 0.19% 76
2023
Q4 		$828K Sell
10,219
-125
-1% -$9.73K 0.12% 113
2023
Q3 		$775K Buy
10,344
+500
+5% +$38.5K 0.12% 118
2023
Q2 		$759K Buy
9,844
+695
+8% +$55.4K 0.12% 117
2023
Q1 		$759K Buy
9,149
+300
+3% +$24.8K 0.2% 75
2022
Q4 		$760K Sell
8,849
-160
-2% -$12.7K 0.29% 38
2022
Q3 		$556K Buy
9,009
+1,845
+26% +$116K 0.25% 36
2022
Q2 		$443K Buy
7,164
+1,547
+28% +$95.8K 0.21% 43
2022
Q1 		$334K Buy
+5,617
New +$359K 0.13% 54
2020
Q2 		– Sell
-1,049
Closed -$78K – 167
2020
Q1 		$78K Buy
+1,049
New +$72.5K 0.06% 89

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AlphaCore Capital's GILD Position: Q2 2026 in Review

AlphaCore Capital increased its Gilead Sciences (GILD) stake by 22% in Q2 2026, buying an estimated $403K and bringing the position to 16,707 shares worth $2.11M. The position accounts for 0.04% of the portfolio, ranked #301.

AlphaCore Capital first reported a position in GILD in Q1 2020 and has held it in 19 quarters since. The position peaked at $2.13M in Q4 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • AlphaCore Capital held 16,707 shares of Gilead Sciences worth $2.11M as of Q2 2026.
  • AlphaCore Capital bought 3,060 Gilead Sciences shares in Q2 2026, an estimated $403K.
  • Gilead Sciences made up 0.04% of AlphaCore Capital's portfolio in Q2 2026, its #301 holding.
  • AlphaCore Capital first reported a position in Gilead Sciences in Q1 2020 and has held it in 19 quarters since.
  • AlphaCore Capital's Gilead Sciences position peaked at $2.13M in Q4 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.